Biopharmaceutics & Pharmacokinetics - 10 Mark Answers
a. Introduction to Bioavailability and Bioequivalence
**Introduction to Bioavailability and Bioequivalence**
Bioavailability refers to the rate and extent to which the active drug ingredient or active moiety is
absorbed from a drug product and becomes available at the site of action. It is an essential
pharmacokinetic property that determines the onset, intensity, and duration of drug action. Absolute
bioavailability compares the bioavailability of the same drug from different dosage forms given by
different routes, while relative bioavailability compares different formulations of the same drug given
by the same route.
Bioequivalence, on the other hand, refers to the absence of a significant difference in the rate and
extent to which the active ingredient becomes available at the site of action when administered at
the same molar dose under similar conditions. Bioequivalence studies are critical for generic drug
approval, ensuring therapeutic equivalence.
According to Brahmankar, both concepts are foundational for understanding drug formulation and
regulatory approval processes, especially in generic drug development. These parameters help
ensure safety, efficacy, and quality control in pharmaceuticals.
Factors influencing bioavailability include drug solubility, dissolution rate, stability in gastrointestinal
fluids, first-pass metabolism, and drug formulation.
Applications:
- Regulatory submissions (ANDA)
- Formulation development
- Therapeutic drug monitoring
b. Bioavailability Study Protocol
**Bioavailability Study Protocol**
A bioavailability study protocol is a structured document that outlines the design, methodology,
a. Introduction to Bioavailability and Bioequivalence
**Introduction to Bioavailability and Bioequivalence**
Bioavailability refers to the rate and extent to which the active drug ingredient or active moiety is
absorbed from a drug product and becomes available at the site of action. It is an essential
pharmacokinetic property that determines the onset, intensity, and duration of drug action. Absolute
bioavailability compares the bioavailability of the same drug from different dosage forms given by
different routes, while relative bioavailability compares different formulations of the same drug given
by the same route.
Bioequivalence, on the other hand, refers to the absence of a significant difference in the rate and
extent to which the active ingredient becomes available at the site of action when administered at
the same molar dose under similar conditions. Bioequivalence studies are critical for generic drug
approval, ensuring therapeutic equivalence.
According to Brahmankar, both concepts are foundational for understanding drug formulation and
regulatory approval processes, especially in generic drug development. These parameters help
ensure safety, efficacy, and quality control in pharmaceuticals.
Factors influencing bioavailability include drug solubility, dissolution rate, stability in gastrointestinal
fluids, first-pass metabolism, and drug formulation.
Applications:
- Regulatory submissions (ANDA)
- Formulation development
- Therapeutic drug monitoring
b. Bioavailability Study Protocol
**Bioavailability Study Protocol**
A bioavailability study protocol is a structured document that outlines the design, methodology,
